Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Etilefrine→

Etilefrine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
709-55-7
Molecular formula
C10H15NO2
Molecular weight
181.2316 g/mol
Drug class
Sympathomimeticalpha- and beta-1 adrenergic receptor agonist
Mechanism of action
Stimulates alpha-adrenergic receptors to increase peripheral vascular tone and beta-1 adrenergic receptors to increase cardiac contractility, thereby increasing blood pressure and cardiac output.
Indications / reported uses
  • Symptomatic treatment of orthostatic hypotension in selected patients where etilefrine is authorised; indications vary by formulation and jurisdiction

Sources: NLM MeSH — Etilefrine · WHO ATC — Etilefrine · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Etilefrine Environmental Risk Assessment (ERA) (the Etilefrine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.